Aquestive Therapeutics, Inc. (AQST) Q1 2025 Earnings Call Transcript
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET
Company Participants
Brian Korb – IR
Dan Barber – CEO
Ernie Toth – CFO
Sherry Korczynski – SVP of Sales and Marketing
Carl Kraus – CMO
Conference Call Participants
Roanna Ruiz – Leerink Partners
David Amsellem – Piper Stanley
Kristen Kluska – Cantor Fitzgerald
Jason Butler – Citizens JMP
Raghuram Selvaraju – HC Wainwright
Dennis Resnick – Raymond James
Nelson Cox – Lake Street Capital Markets
Operator
Good day and thank you for standing by. Welcome to the Aquestive Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised today’s conference is being recorded.
I would now like to turn the conference over to your host today, Brian Korb. Please go ahead.
Brian Korb
Thank you, operator. Good morning, and welcome to today’s call. On today’s call, I am joined by Dan Barber, Chief Executive Officer and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance for the first quarter 2025, followed by a Q&A session.
During the Q&A session, the team will be joined by Dr. Carl Kraus, Chief Medical Officer and Sherry Korczynski, Senior Vice President, Sales and Marketing. As a reminder, the company’s remarks today correspond with the earnings release that was issued after market closed yesterday.
In addition, a recording of today’s call will be made available on Aquestive’s website within the Investors section shortly following the conclusion of this call. To remind you, the Aquestive team will be discussing some non-GAAP financial measures this morning as part of its review of first quarter 2025 results.
A description of these
